The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Jesus Berdeja | EHA 2018 | The CRB-401 phase I bb2121 CAR T-cell study

Jun 17, 2018

23rd Congress of European Hematology Association, 14-17 June 2018, Stockholm, Sweden

Jesus Berdeja
Sarah Cannon Research Institute, Nashville, US

Interview topic: Summary of results from the CRB-401 phase I bb2121 CAR-T cell study

The CRB-401 phase I bb2121 CAR T-cell study